UCLA Health

Infection Prevention

Begin main content

Major Projects & Initiatives

Hand Hygiene Electronic Compliance Monitoring System Information

If you have any questions regarding Hand Hygiene, please contact us at: HandHygiene@mednet.ucla.edu

Prevention of Surgical Site Infections (SSI)

CEIP performs SSI surveillance and is actively involved in sterile processing and disinfection efforts across UCLA Health. CEIP is implementing CHG bathing for pre-op patients plus a specific S. aureus decolonization protocol using CHG + intranasal mupirocin.

Prevention of Clostridium difficile Infection (C. diff)

A number of important strategies are being implemented to decrease the burden of C. diff at UCLA. Antimicrobial Stewardship, led by Tara Vijayan, MD, MPH has achieved recent success in curbing antibiotic utilization. Dr. Vijayan is also looking at PPI utilization and its impact on healthcare-associated CDI. CEIP has partnered with Environmental Services to bring UV disinfection to UCLA. UV-C disinfection is now being used each shift for C.difficile discharges.

Reducing catheter associated blood stream infections (CLABSI)

Reducing the risk of CLABSI is a key focus of CEIP. UCLA's CLABSI Task Force has tackled CLABSIs head-on by using a multidisciplinary approach to implement the following:

  • CHG bathing for all ICU patients plus acute care patients with central lines
  • Comprehensive resident and fellow central line insertion training for programs including surgery, medicine, anesthesia, emergency medicine, family medicine, pediatrics, obstetrics & gynecology
  • Ethanol lock therapy
  • Support for direct care provider campaigns such as "Scrub the Hub"
  • Continuous evaluation of new products for line insertion, maintenance and access

Reducing catheter associated urinary tract infections (CAUTI)

CAUTI is an up and coming area for CEIP. CEIP collaborates with nursing units to reduce the risk of CAUTI and improve patient outcomes. CEIP is currently involved in the "On the CUSP: Stop CAUTI" UHC Collaborative, which aims to both improve the unit-based culture of safety and reduce CAUTI rates. Interventions aimed at insertion and removal of indwelling urinary catheters are on the horizon for CEIP.

Reducing Ventilator associated pneumonia (VAP)

CEIP has worked closely with critical care physician and nursing leadership to implement the VAP bundle. CEIP (including Antimicrobial Stewardship) has been an integral part of creating prevention, diagnosis, and treatment guidelines for physicians, and co-authors order sets for VAP prevention. CEIP collaborates with physician teams and respiratory therapy regarding utilization of sensitive diagnostic tools and new technology.

Media Features

UCLA Health News & Insights    
UCLA Health’s early use of electronic records system aids in curbing the spread of deadly fungus 

UCLA Health U News    
Spotlight on U: Eve Bluntson 

Zocalo Public Square    
The Hidden Health Care Workers Keeping Hospitals Safe

48th Annual Conference of Association for Professionals in Infection Control and Epidemiology’s (APIC)    
Meet the Infection Preventionists at the Front Lines of the Pandemic Battle

Healio - Infectious Disease News    
Preventive Measures Stopped C. Auris Outbreaks At Two California Hospitals

Contagion Live - Infectious Diseases Today
Preventing a Candida Auris Outbreak in the Health Care Setting

Innovation and Research

Antimicrobial Stewardship Program:

The Antimicrobial Stewardship Program is involved in numerous multidisciplinary projects including studying antimicrobial benchmarking, risk adjustment, impact of education on antibiotic utilization, and survey research of house staff.

Copper:

Hospital-acquired infections are a huge public health burden, and hospital environments play a key role in harboring potentially deadly bacteria such as E. coli, C. difficile and methicillin-resistant Staphylococcus aureus. Copper surfaces, which are not routinely used in hospitals, are known to kill bacteria on contact, and studies have found much lower levels of bacteria living on copper surfaces than on standard hospital surfaces. In one of the first randomized clinical trials of its kind, UCLA researchers will determine if the reduction of surface bacteria due to the use of copper will result in a decreased number of hospital-acquired infections.

Real Time Location Tracking:

While placing patients in contact isolation has become the standard of care for patients colonized or infected with certain microorganisms, there are numerous drawbacks to doing so. These potentially include emotional isolation, fewer or less frequent visits by healthcare providers, and family anxiety. This study is using novel technology produced by Awarepoint to track Internal Medicine residents as they care for patients with and without contact isolation. We are measuring physician visit frequency, contact time, and work flow.

Publications

  • Gray HK, Bisht A, Caldera JR, Fossas Braegger NM, Cambou MC, Sakona AN, Beaird OE, Uslan DZ, Walton SC, Yang S. Nosocomial Infections by Diverse Carbapenemase-producing Aeromonas hydrophila Associated with Combination of Plumbing Issues and Heat Waves. Am J Infect Control. 2023 Sep 29:S0196-6553(23)00654-5. doi: 10.1016/j.ajic.2023.09.013. Epub ahead of print. PMID: 37778710.
  • Xu K, Finn LE, Geist RL, et al. Mycobacterium chimaera infections among cardiothoracic surgery patients associated with heater-cooler devices-Kansas and California, 2019. Infect Control Hosp Epidemiol. 2022;43(10):1333-1338.
  • Waldman SE, Buehring T, Escobar DJ, et al. Secondary Cases of Delta Variant Coronavirus Disease 2019 Among Vaccinated Healthcare Workers With Breakthrough Infections is Rare. Clin Infect Dis. 2022;75(1):e895-e897.
  • Viloria Winnett A, Srinivasan V, Davis M, et al. The Path of More Resistance: a Comparison of National Healthcare Safety Network and Clinical Laboratory Standards Institute Criteria in Developing Cumulative Antimicrobial Susceptibility Test Reports and Institutional Antibiograms. J Clin Microbiol. 2022;60(2):e0136621.
  • Srinivasan V, Gohil SK, Abeles SR, et al. Finding a needle in a haystack: The hidden costs of asymptomatic testing in a low incidence setting. Infect Control Hosp Epidemiol. 2022;43(10):1525-1526.
  • de St Maurice A, Parti U, Anikst VE, et al. Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019-2022. Infect Control Hosp Epidemiol. 2022:1-9.
  • Adamson PC, Currier JS, Uslan DZ, Garner OB. Prevalence and Factors Associated With Antigen Test Positivity Following SARS-CoV-2 Infection Among Health Care Workers in Los Angeles. Open Forum Infect Dis. 2022;9(10):ofac462.
  • Zunner-Keating BP, Alberto PJ, Sweeney SJ, et al. Rapid implementation of ultraviolet germicidal irradiation and reuse processes for N95 respirators at a health system during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021;42(11):1379-1381.
  • Yang S, Stanzione N, Uslan DZ, Garner OB, de St Maurice A. Clinical and Epidemiologic Evaluation of Inconclusive COVID-19 PCR Results Using a Quantitative Algorithm. Am J Clin Pathol. 2021;155(3):376-380.
  • Price TK, Mirasol R, Ward KW, et al. Genomic Characterizations of Clade III Lineage of Candida auris, California, USA. Emerg Infect Dis. 2021;27(4):1223-1227.
  • Furukawa D, Dieringer TD, Wong MD, et al. Evaluation of antibiotic escalation in response to nurse-driven inpatient sepsis screen. Antimicrob Steward Healthc Epidemiol. 2021;1(1):e59.
  • Davar K, Pilkington MN, Powers J, Busuttil A, Lee R, Uslan D. Infectious disease screening lab panel for homeless patients: A retrospective review at a large academic health system. Infect Control Hosp Epidemiol. 2021;42(4):487-488.
  • Chang SY, Bisht A, Faysman K, Schiller GJ, Uslan DZ, Multani A. Vaccine-Associated Measles in a Hematopoietic Cell Transplant Recipient: Case Report and Comprehensive Review of the Literature. Open Forum Infect Dis. 2021;8(8):ofab326.
  • Brown J, Bhatnagar M, Gordon H, et al. Clinical Data Extraction During Public Health Emergencies: A Blockchain Technology Assessment. Biomed Instrum Technol. 2021;55(3):103-111.
  • Bartlett AH, Ravin KA, Rubin LG, et al. SHEA Pediatric Leadership Council commentary: Inpatient visitor considerations for pediatric patients during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021;42(11):1369-1371.
  • Parti U, Walton S, Finn L, et al. The Importance of Information Technology and Surveillance to Prevent the Spread of Candida Auris. American Journal of Infection Control. 2021;49(6):S8. doi:10.1016/j.ajic.2021.04.032
  • Singer JS, Cheng EM, Murad DA, et al. Low prevalence (0.13%) of COVID-19 infection in asymptomatic pre-operative/pre-procedure patients at a large, academic medical center informs approaches to perioperative care. Surgery. 2020;168(6):980-986.
  • Shahbaz S, de St Maurice A, Sim MS, Rubin Z, Garg M. Effect of Contact Precautions on Staphylococcus aureus and Clinical Outcomes of Colonized Patients in the Neonatal Intensive Care Unit. Pediatr Infect Dis J. 2020;39(11):1045-1049.
  • Sadeghzadeh CJ, Soldavini J, Uslan D, De Marco M. Novel Sales Tracking Method to Evaluate a Healthy Corner Store Intervention. Health Promot Pract. 2020;21(3):401-409.
  • Merselis LC, Jiang SY, Nelson SF, et al. MPEG1/Perforin-2 Haploinsufficiency Associated Polymicrobial Skin Infections and Considerations for Interferon-gamma Therapy. Front Immunol. 2020;11:601584.
  • Hilt EE, Fitzwater SP, Ward K, et al. Carbapenem Resistant Aeromonas hydrophila Carrying bla cphA7 Isolated From Two Solid Organ Transplant Patients. Front Cell Infect Microbiol. 2020;10:563482.
  • Haessler S, Martin EM, Scales ME, et al. Stopping the routine use of contact precautions for management of MRSA and VRE at three academic medical centers: An interrupted time series analysis. Am J Infect Control. 2020;48(12):1466-1473.
  • Baghdadi JD, Wong MD, Uslan DZ, et al. Adherence to the SEP-1 Sepsis Bundle in Hospital-Onset v. Community-Onset Sepsis: a Multicenter Retrospective Cohort Study. J Gen Intern Med. 2020;35(4):1153-1160.
  • Baghdadi JD, Uslan DZ, Wong MD. SEP-1 Septic Shock Bundle Guidelines Not Applicable to Inpatients-Reply. JAMA Intern Med. 2020;180(12):1713-1714.
  • Baghdadi JD, Brook RH, Uslan DZ, et al. Association of a Care Bundle for Early Sepsis Management With Mortality Among Patients With Hospital-Onset or Community-Onset Sepsis. JAMA Intern Med. 2020;180(5):707-716.
  • Altendahl M, Afshar Y, de St Maurice A, Fajardo V, Chu A. Perinatal Maternal-Fetal/Neonatal Transmission of COVID-19: A Guide to Safe Maternal and Neonatal Care in the Era of COVID-19 and Physical Distancing. Neoreviews. 2020;21(12):e783-e794.
  • Richter SE, Miller L, Needleman J, et al. Risk Factors for Development of Carbapenem Resistance Among Gram-Negative Rods. Open Forum Infect Dis. 2019;6(3):ofz027.
  • Richter SE, Miller L, Needleman J, et al. Risk factors for development of aminoglycoside resistance among gram-negative rods. Am J Health Syst Pharm. 2019;76(22):1838-1847.
  • Powell LM, Singleton CR, Li Y, et al. Changes to SNAP-authorized retailer stocking requirements and the supply of foods and beverages in low-income communities in seven U.S. states. Transl Behav Med. 2019;9(5):857-864.
  • Oh TS, Le K, Baddour LM, et al. Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes. Pacing Clin Electrophysiol. 2019;42(10):1331-1339.
  • Tran V, Phan J, Nulsen B, et al. Severe Ileocolonic Crohn's Disease Flare Associated with Fecal Microbiota Transplantation Requiring Diverting Ileostomy. ACG Case Rep J. 2018;5:e97.
  • Simonsen L, Higgs E, Taylor RJ, et al. Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic. Clin Infect Dis. 2018;67(3):341-349.
  • Russell DL, Uslan DZ, Rubin ZA, Grogan TR, Martin EM. Multidrug Resistant Acinetobacter baumanii: A 15-Year Trend Analysis. Infect Control Hosp Epidemiol. 2018;39(5):608-611.
  • Richter SE, Miller L, Uslan DZ, et al. Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates. J Clin Microbiol. 2018;56(9).
  • Pett SL, Kunisaki KM, Wentworth D, et al. Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study. Open Forum Infect Dis. 2018;5(1):ofx228.
  • Peacock JE, Jr., Stafford JM, Le K, et al. Attempted salvage of infected cardiovascular implantable electronic devices: Are there clinical factors that predict success? Pacing Clin Electrophysiol. 2018;41(5):524-531.
  • Martin EM, Bryant B, Grogan TR, et al. Noninfectious Hospital Adverse Events Decline After Elimination of Contact Precautions for MRSA and VRE. Infect Control Hosp Epidemiol. 2018;39(7):788-796.
  • Harper MW, Uslan DZ, Greenspon AJ, et al. Clinical presentation of CIED infection following initial implant versus reoperation for generator change or lead addition. Open Heart. 2018;5(1):e000681.
  • Ellis O, Godwin H, David M, Morse DJ, Humphries R, Uslan DZ. How to better monitor and clean irregular surfaces in operating rooms: Insights gained by using both ATP luminescence and RODAC assays. Am J Infect Control. 2018;46(8):906-912.
  • Boyle TA, Uslan DZ, Prutkin JM, et al. Impact of Abandoned Leads on Cardiovascular Implantable Electronic Device Infections: A Propensity Matched Analysis of MEDIC (Multicenter Electrophysiologic Device Infection Cohort). JACC Clin Electrophysiol. 2018;4(2):201-208.
  • Baghdadi JD, Wong M, Comulada WS, Uslan DZ. Lack of insurance as a barrier to care in sepsis: A retrospective cohort study. J Crit Care. 2018;46:134-138.
  • Humphries RM, Yang S, Kim S, et al. Duodenoscope-Related Outbreak of a Carbapenem-Resistant Klebsiella pneumoniae Identified Using Advanced Molecular Diagnostics. Clin Infect Dis. 2017;65(7):1159-1166.
  • Dwyer DE, Lynfield R, Losso MH, et al. Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009-2015. Open Forum Infect Dis. 2017;4(4):ofx212.
  • Boyle TA, Uslan DZ, Prutkin JM, et al. Reimplantation and Repeat Infection After Cardiac-Implantable Electronic Device Infections: Experience From the MEDIC (Multicenter Electrophysiologic Device Infection Cohort) Database. Circ Arrhythm Electrophysiol. 2017;10(3).
  • Alvarez E, Uslan D, Malloy T, Sinsheimer P, Godwin H. Response to "Perspectives from the field in response to 'It is time to revise our approach to registering antimicrobial agents [by the Environmental Protection Agency] for health care settings'". Am J Infect Control. 2017;45(1):100-102.
  • Russell D, Beekmann SE, Polgreen PM, Rubin Z, Uslan DZ. Routine Use of Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: Which Way Is the Pendulum Swinging? Infect Control Hosp Epidemiol. 2016;37(1):36-40.
  • Martin EM, Russell D, Rubin Z, et al. Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study. Infect Control Hosp Epidemiol. 2016;37(11):1323-1330.
  • Kelesidis T, Braykov N, Uslan DZ, et al. Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009-2010: A Pragmatic Retrospective Observational Study. Infect Control Hosp Epidemiol. 2016;37(1):70-79.
  • Jilcott Pitts SB, McGuirt JT, Wu Q, et al. Assessing Preliminary Impact of the North Carolina Community Transformation Grant Project Farmers' Market Initiatives Among Rural Residents. J Nutr Educ Behav. 2016;48(5):343-349.e341.
  • Bryant B, Curello J, Uslan D, Humphries R, Kanatani M, Kassamali Z. Antimicrobial Stewardship Programs: Engaging Project Managers to Increase Productivity. Infect Control Hosp Epidemiol. 2016;37(6):739-740.
  • Alvarez E, Uslan DZ, Malloy T, Sinsheimer P, Godwin H. It is time to revise our approach to registering antimicrobial agents for health care settings. Am J Infect Control. 2016;44(2):228-232.
  • Sohail MR, Palraj BR, Khalid S, et al. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol. 2015;8(1):137-144.
  • Prutkin JM, Reynolds MR, Bao H, et al. Response to letter regarding article, "Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry". Circulation. 2015;131(22):e518.
  • Chung MK, Holcomb RG, Mittal S, et al. Response to Letter Regarding "REPLACE DARE (Death After Replacement Evaluation) Score: Determinants of All-Cause Mortality After Implantable Device Replacement Or Upgrade From the REPLACE Registry". Circ Arrhythm Electrophysiol. 2015;8(2):514-515.
  • Welch M, Uslan DZ, Greenspon AJ, et al. Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections. Pacing Clin Electrophysiol. 2014;37(8):955-962.
  • Stavrakis AI, Niska JA, Shahbazian JH, et al. Combination prophylactic therapy with rifampin increases efficacy against an experimental Staphylococcus epidermidis subcutaneous implant-related infection. Antimicrob Agents Chemother. 2014;58(4):2377-2386.
  • Prutkin JM, Reynolds MR, Bao H, et al. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation. 2014;130(13):1037-1043.
  • Pollett S, Miller S, Hindler J, Uslan D, Carvalho M, Humphries RM. Phenotypic and molecular characteristics of carbapenem-resistant Enterobacteriaceae in a health care system in Los Angeles, California, from 2011 to 2013. J Clin Microbiol. 2014;52(11):4003-4009.
  • Lynfield R, Davey R, Dwyer DE, et al. Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies. PLoS One. 2014;9(7):e101785.
  • Greenspon AJ, Le KY, Prutkin JM, et al. Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry. JACC Cardiovasc Imaging. 2014;7(6):541-549.
  • Frank PN, Palma Diaz MF, Uslan DZ, Yeh MW. Histoplasmosis mimicking malignant adenopathy during diagnostic thyroid lobectomy. JAMA Otolaryngol Head Neck Surg. 2014;140(7):664-666.
  • Dashiell-Earp CN, Bell DS, Ang AO, Uslan DZ. Do physicians spend less time with patients in contact isolation?: a time-motion study of internal medicine interns. JAMA Intern Med. 2014;174(5):814-815.
  • Chung MK, Holcomb RG, Mittal S, et al. REPLACE DARE (Death After Replacement Evaluation) score: determinants of all-cause mortality after implantable device replacement or upgrade from the REPLACE registry. Circ Arrhythm Electrophysiol. 2014;7(6):1048-1056.
  • Braykov NP, Morgan DJ, Schweizer ML, et al. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis. 2014;14(12):1220-1227.
  • Saira K, Lin X, DePasse JV, et al. Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus. J Virol. 2013;87(14):8064-8074.
  • Kelesidis T, Humphries R, Chow ALP, Tsiodras S, Uslan DZ. Emergence of daptomycin-non-susceptible enterococci urinary tract isolates. J Med Microbiol. 2013;62(Pt 7):1103-1105.
  • Johnson SW, Kanatani M, Humphries RM, Uslan DZ. Clinical impact of switching conventional enzyme immunoassay with nucleic acid amplification test for suspected Clostridium difficile-associated diarrhea. Am J Infect Control. 2013;41(4):373-375.
  • Humphries RM, Uslan DZ, Rubin Z. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity. J Clin Microbiol. 2013;51(3):869-873.
  • Giltner CL, Bobenchik AM, Uslan DZ, Deville JG, Humphries RM. Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapy. J Clin Microbiol. 2013;51(4):1324-1326.
  • Davey RT, Jr., Lynfield R, Dwyer DE, et al. The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies. PLoS One. 2013;8(2):e57121.
  • Uslan DZ, Gleva MJ, Warren DK, et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry. Pacing Clin Electrophysiol. 2012;35(1):81-87.
  • Le KY, Sohail MR, Friedman PA, et al. Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species. Am J Cardiol. 2012;110(8):1143-1149.
  • Kelesidis T, Humphries R, Uslan DZ, Pegues D. De novo daptomycin-nonsusceptible enterococcal infections. Emerg Infect Dis. 2012;18(4):674-676.
  • Kelesidis T, Chow AL, Humphries R, Uslan DZ, Pegues D. Case-control study comparing de novo and daptomycin-exposed daptomycin-nonsusceptible Enterococcus infections. Antimicrob Agents Chemother. 2012;56(4):2150-2152.
  • Greenspon AJ, Prutkin JM, Sohail MR, et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol. 2012;59(7):681-687.
  • Sohail MR, Hussain S, Le KY, et al. Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol. 2011;31(2):171-183.
  • Le KY, Sohail MR, Friedman PA, et al. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011;8(11):1678-1685.
  • Le KY, Sohail MR, Friedman PA, et al. Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol. 2011;34(4):450-459.
  • Kelesidis T, Humphries R, Uslan DZ, Pegues DA. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis. 2011;52(2):228-234.
  • Green JS, Abeles SR, Uslan DZ, Mehta SR. Persistent neutrophilic meningitis in an immunocompetent patient after basilar skull fracture: case report. BMC Infect Dis. 2011;11:136.
  • Dwyer DE. Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies. Vaccine. 2011;29 Suppl 2(0 2):B56-62.
  • Cho JS, Zussman J, Donegan NP, et al. Noninvasive in vivo imaging to evaluate immune responses and antimicrobial therapy against Staphylococcus aureus and USA300 MRSA skin infections. J Invest Dermatol. 2011;131(4):907-915.
  • Uslan DZ, Dowsley TF, Sohail MR, et al. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol. 2010;33(4):407-413.
  • Tsui I, Uslan DZ, Hubschman JP, Deng SX. Nocardia farcinica Infection of a Baerveldt implant and endophthalmitis in a patient with a Boston type I keratoprosthesis. J Glaucoma. 2010;19(5):339-340.
  • Poole JE, Gleva MJ, Mela T, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122(16):1553-1561.
  • Mitter SS, Derhovanessian A, Hillman JD, Uslan DZ. Disseminated coccidioidomycosis in a patient managed with adalimumab for Crohn's disease. Nat Rev Gastroenterol Hepatol. 2010;7(4):231-235.
  • Kelesidis T, Salhotra A, Fleisher J, Uslan DZ. Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections? J Infect. 2010;60(5):386-396.
  • Kelesidis T, Dien Bard J, Humphries R, Ward K, Lewinski MA, Uslan DZ. First report of treatment of Anaerobiospirillum succiniciproducens bloodstream infection with levofloxacin. J Clin Microbiol. 2010;48(5):1970-1973.
  • Gorgulho A, Juillard C, Uslan DZ, et al. Infection following deep brain stimulator implantation performed in the conventional versus magnetic resonance imaging-equipped operating room. J Neurosurg. 2009;110(2):239-246.
  • Cesario D, Kedia R, Desai N, et al. Device extraction in adults with congenital heart disease. Pacing Clin Electrophysiol. 2009;32(3):340-345.
  • Uslan DZ, Tleyjeh IM, Baddour LM, et al. Temporal trends in permanent pacemaker implantation: a population-based study. Am Heart J. 2008;155(5):896-903.
  • Uslan DZ, Patel R, Virk A. International travel and exposure risks in solid-organ transplant recipients. Transplantation. 2008;86(3):407-412.
  • Uslan DZ. Infections of electrophysiologic cardiac devices. Expert Rev Med Devices. 2008;5(2):183-195.
  • Sohail MR, Uslan DZ, Khan AH, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008;83(1):46-53.
  • Lin G, Meverden RA, Hodge DO, Uslan DZ, Hayes DL, Brady PA. Age and gender trends in implantable cardioverter defibrillator utilization: a population based study. J Interv Card Electrophysiol. 2008;22(1):65-70.
  • Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167(7):669-675.
  • Uslan DZ, Crane SJ, Steckelberg JM, et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med. 2007;167(8):834-839.
  • Sohail MR, Uslan DZ, Khan AH, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007;45(2):166-173.
  • Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49(18):1851-1859.
  • Crane SJ, Uslan DZ, Baddour LM. Bloodstream infections in a geriatric cohort: a population-based study. Am J Med. 2007;120(12):1078-1083.
  • Uslan DZ, Sohail MR, Friedman PA, et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis. 2006;43(6):731-736.
  • Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol. 2006;142(10):1287-1292.
  • Uslan DZ, Jacobson KM, Kumar N, Berbari EF, Orenstein R. A woman with fever and rash after African safari. Clin Infect Dis. 2006;43(5):609, 661-602.
  • Uslan DZ, Baddour LM. Cardiac device infections: getting to the heart of the matter. Curr Opin Infect Dis. 2006;19(4):345-348.
  • Kumar N, Orenstein R, Uslan DZ, Berbari EF, Klein CJ, Windebank AJ. Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis. Neurology. 2006;66(7):1120-1121.
  • Uslan DZ, Virk A. Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus in traveling health care workers. J Travel Med. 2005;12(1):14-18.
  • Batsis JA, Uslan DZ, Baddour LM. 70-year-old man with fever, shaking chills, and weakness. Mayo Clin Proc. 2005;80(9):1209-1212.
  • Wilson FC, Uslan DZ. Delusional parasitosis. Mayo Clin Proc. 2004;79(11):1470.
  • Uslan DZ, Sia IG. African tick-bite fever. Mayo Clin Proc. 2004;79(8):1007.
  • Mirzoyev Z, Anavekar N, Wilson F, Uslan D, Baddour L, Mookadam F. Enterococcus avium endocarditis. Scand J Infect Dis. 2004;36(11-12):876-878.
  • Ghobrial IM, Uslan DZ, Call TG, Witzig TE, Gertz MA. Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response. Am J Hematol. 2004;77(4):329-330.
  • Assefi NP, Coy TV, Uslan D, Smith WR, Buchwald D. Financial, occupational, and personal consequences of disability in patients with chronic fatigue syndrome and fibromyalgia compared to other fatiguing conditions. J Rheumatol. 2003;30(4):804-808.
  • Overman SS, Kent DL, Uslan DW, Lewis RS. Cost of care and patient-satisfaction from routine referral to nonsurgical musculoskeletal specialists in a medicare risk plan. J Clin Rheumatol. 1998;4(3):120-128.